下载本文档
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
Hotline:400-820-3792Inhibitors•ScreeningLibraries•Proteinswww.MedChemEAcetaminophenCat.No.:HY-66005CASNo.:103-90-2Synonyms:Paracetamol;4-Acetamidophenol;4'-Hydroxyacetanilide分⼦式:C₈H₉NO₂分⼦量:151.16作⽤靶点:COX;HistoneAcetyltransferase;EndogenousMetabolite;Bacterial;Parasite作⽤通路:Immunology/Inflammation;Epigenetics;MetabolicEnzyme/Protease;Anti-infection储存⽅式:Powder-20°C3years4°C2years*该产品在溶液状态不稳定,建议您现⽤现配,即刻使⽤。溶解性数据体外实验DMSO:250mg/mL(1653.88mM;Needultrasonic)H2O:10mg/mL(66.16mM;Needultrasonic)MassSolvent1mg5mg10mgConcentration制备储备液1mM6.6155mL33.0775mL66.1551mL5mM1.3231mL6.6155mL13.2310mL10mM0.6616mL3.3078mL6.6155mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液;该产品在溶液状态不稳定,建议您现⽤现配,即刻使⽤.体内实验请根据您的实验动物和给药⽅式选择适当的溶解⽅案。以下溶解⽅案都请先按照InVitro⽅式配制澄的储备液,再依次添加助溶剂:(为保证实验结果的可靠性,澄的储备液可以根据储存条件,适当保存;体内实验的⼯作液,建议您现⽤现配,当天使⽤;以下溶剂前显⽰的百分⽐指该溶剂在您配制终溶液中的体积占⽐;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的⽅式助溶)1/3MasterofBioactiveMolecules—您⾝边的抑制剂⼤师www.MedChemE1.请依序添加每种溶剂:0.5%CMC-Na/salinewaterSolubility:10mg/mL(66.16mM);Suspendedsolution;Needultrasonic2.请依序添加每种溶剂:10%DMSO>>40%PEG300>>5%Tween-80>>45%salineSolubility:≥2.08mg/mL(13.76mM);Clearsolution3.请依序添加每种溶剂:10%DMSO>>90%(20%SBE-β-CDinsaline)Solubility:≥2.08mg/mL(13.76mM);Clearsolution4.请依序添加每种溶剂:10%DMSO>>90%cornoilSolubility:≥2.08mg/mL(13.76mM);Clearsolution5.请依序添加每种溶剂:PBSSolubility:6.67mg/mL(44.13mM);Clearsolution;Needultrasonic6.请依序添加每种溶剂:saline>>0.5%Tween-80Solubility:10mg/mL(66.16mM);Clearsolution;NeedultrasonicBIOLOGICALACTIVITY⽣物活性Acetaminophen(Paracetamol)选择性环氧合酶-2(COX-2)的抑制剂,IC50值为25.8μM。Acetaminophen⼀种有效的肝N-⼄酰转移酶2(NAT2)抑制剂。Acetaminophen⼴泛使⽤的解热和⽌痛剂[1][2][3][4]。IC50&TargetCOX-2COX-125.8μM(IC50)113.7μM(IC50)体外研究Invitro,acetaminophenelicitesa4.4-foldselectivitytowardCOX-2inhibition(IC50113.7μMforCOX-1;IC5025.8μMforCOX-2).Followingoraladministrationofthedrug,maximalexvivoinhibitionsare56%(COX-1)and83%(COX-2).AcetaminophenplasmaconcentrationsremaineabovetheinvitroIC50forCOX-2foratleast5hpostadministration.ExvivoIC50values(COX-1:105.2μM;COX-2:26.3μM)ofacetaminophencomparedfavorablywithitsinvitroIC50values.Incontrasttopreviousconcepts,acetaminopheninhibitedCOX-2bymorethan80%,i.e.,toadegreecomparabletononsteroidalantiinflammatorydrugs(NSAIDs)andselectiveCOX-2inhibitors.However,a>95%COX-1blockaderelevantforsuppressionofplateletfunctionisnotachieved[1].MTTassayshowsthatAcetaminophen(APAP)inadoseof50mMsignificantly(p[2].体内研究AdministeringAcetaminophen(250ꢀmg/kg,orally)tothemicecausessignificant(p[3].PROTOCOLCellAssay[2]HumanhepatomacelllineHepG2isculturedinlowglucoseDMEMsupplementedwith10%fetalbovineserum(FBS),100U/mLPenicillinand100μg/mLStreptomycinand2mMl-glutamine.Thecellsaremaintainedin75cm2flasksat37°Cinahumidifiedatmospherecontaining5%CO2andsplitat80%confluenceevery5days.Cellsareseededin24-wellplate(2×105cells)andincubatedat37°CovernightfollowedbycellspretreatmentwithcompleteDMEMcontaininghighglucoseconcentrationinordertodownregulateautophagy.After6h,cellsaretreatedwithdifferentconcentrationsofpostbioticsobtainedfromLactobacillusfermentumBGHV110strain(HV110)inordertoselectappropriatedoseforfurther2/3MasterofBioactiveMolecules—您⾝边的抑制剂⼤师www.MedChemEexperiments.PostbioticisdissolvedincompleteDMEMmediumandaddedtothecellsinspecificfinalconcentration.Inallotherexperimentsseededcellsaretreatedwith50mMAcetaminophenaloneorco-treatedwith50mMAcetaminophenandselecteddoseoflyophilizedHV110.Toanalyzeautophagicflux,simultaneouslywithtreatments,cellsareexposedtolysosomotropicagentChloroquineataconcentrationof25μM,toinhibitautophagosome-lysosomefusion[2].MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly.AnimalMice[3]Administration[3]MaleSwissmice(30-40ꢀg)areused.Theexperimentalanimalsaredividedintosixgroupsoffiveanimalseach.Firstly,eachgroupreceiveorallyduringsevendaysthefollowingtreatment:GroupI:themicedonotreceiveanytreatment(normal).GroupII:themicereceivecitralvehicle(0.1%Tween80solution).GroupsIII-V:themicearepretreatedwithcitralatdosesof125,250,and500ꢀmg/kg,respectively.GroupVI:themicearepretreatedwiththehepatoprotectivestandarddrugSilymarin(SLM)(200ꢀmg/kg).Afterthistime,theanimalsfastedfor8ꢀhandthenreceiveoralAcetaminophenontheseventhdayatadoseof250ꢀmg/kginGroupsII-VI.GroupIorallyreceivesalinethatcontained0.1%Tween80solution(Acetaminophenvehicle).Thestocksolutionisusedasthefirstconcentrationof50ꢀmg/mLandafterthatisdilutedin0.1%Tween80solutiontopreparethesolutionsof25and12.5ꢀmg/mL.After12ꢀhofAcetaminophenadministration,serumsamplesandlivertissuearecollectedfollowedbybiochemistryandhistologicalanalysis.MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly.户使⽤本产品发表的科研⽂献•NatCommun.2021Sep20;12(1):5548.•NatCommun.2021Aug26;12(1):5131.•NatCommun.2021May17;12(1):2863.•Hepatology.2022Jun17.•Theranostics.2017Sep26;7(17):4135-4148.Seemorecustomervalidationsonwww.MedChemEREFERENCES[1].Hinz,B,etal.Acetaminophen(paracetamol)isaselectivecyclooxygenase-2inhibitorinman.FASEBJ,2008.22(2):p.383-90.[2].MiroslavDinić,etal.LactobacillusfermentumPostbiotic-inducedA
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 种植桑黄方法
- 电缆线购买合同 购买电线合同
- 短视频创作者与经纪公司2024年度合作协议
- 2024年度金融投资与理财服务合同3篇
- 泵车租赁协议
- 二零二四年农业科研基地草坪除草合同
- 电梯维修合同范本
- 2024年度电梯门系统升级与改造合同3篇
- 玻璃容器生产与销售合同(04版)
- 二零二四年度设备采购合同
- 公司内部市场化实施方案
- 浙江省公路山岭隧道机械化装备应用指导手册
- 医师定期考核简易程序练习及答案
- 医院科教科工作计划
- 随机前沿生产函数
- 人才培养方案实施总结
- 各航空公司机型介绍
- 新版入团志愿书入团志愿书
- 2022年2022年高中物理《生活中的圆周运动》说课稿
- 北京地铁受电弓的维护与故障检修-毕业设计说明书
- 三相变压器的参数测定实验报告
评论
0/150
提交评论